Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Apr 07 2026

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-apr-07-2026-15

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg.".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases